Saving Lives Through Early Cancer Detection
DELFI Diagnostics pioneers fragmentomics technology, analyzing cell-free DNA fragments from blood samples using advanced machine learning and next-generation sequencing for early cancer detection and monitoring. Their DELFI platform scans millions of data points to identify cancer signals with high sensitivity, supporting providers and pharma in treatment decisions. Developed by experts in genomics, AI, and cancer biology.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2025
Jul 2022
Jan 2021
Jun 2019
Create a free account to see which investors have funded this company.
Create Free AccountAI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Anduril Industries is a defense technology company with a mission to transform US and allied mili...
